Correlation Between HUTCHMED DRC and Dianthus Therapeutics
Can any of the company-specific risk be diversified away by investing in both HUTCHMED DRC and Dianthus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HUTCHMED DRC and Dianthus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HUTCHMED DRC and Dianthus Therapeutics, you can compare the effects of market volatilities on HUTCHMED DRC and Dianthus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HUTCHMED DRC with a short position of Dianthus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HUTCHMED DRC and Dianthus Therapeutics.
Diversification Opportunities for HUTCHMED DRC and Dianthus Therapeutics
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between HUTCHMED and Dianthus is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding HUTCHMED DRC and Dianthus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dianthus Therapeutics and HUTCHMED DRC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HUTCHMED DRC are associated (or correlated) with Dianthus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dianthus Therapeutics has no effect on the direction of HUTCHMED DRC i.e., HUTCHMED DRC and Dianthus Therapeutics go up and down completely randomly.
Pair Corralation between HUTCHMED DRC and Dianthus Therapeutics
Considering the 90-day investment horizon HUTCHMED DRC is expected to generate 0.83 times more return on investment than Dianthus Therapeutics. However, HUTCHMED DRC is 1.21 times less risky than Dianthus Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Dianthus Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 1,745 in HUTCHMED DRC on August 30, 2024 and sell it today you would earn a total of 98.00 from holding HUTCHMED DRC or generate 5.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
HUTCHMED DRC vs. Dianthus Therapeutics
Performance |
| Timeline |
| HUTCHMED DRC |
| Dianthus Therapeutics |
HUTCHMED DRC and Dianthus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HUTCHMED DRC and Dianthus Therapeutics
The main advantage of trading using opposite HUTCHMED DRC and Dianthus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HUTCHMED DRC position performs unexpectedly, Dianthus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dianthus Therapeutics will offset losses from the drop in Dianthus Therapeutics' long position.| HUTCHMED DRC vs. Emergent Biosolutions | HUTCHMED DRC vs. Bausch Health Companies | HUTCHMED DRC vs. Neurocrine Biosciences | HUTCHMED DRC vs. Teva Pharma Industries |
| Dianthus Therapeutics vs. Sun Country Airlines | Dianthus Therapeutics vs. Hasbro Inc | Dianthus Therapeutics vs. Procter Gamble | Dianthus Therapeutics vs. Planet Fitness |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |